Skip to main content

SETU to advance ocular disease research with €3.1m funding

SETU to advance ocular disease research with €3.1m funding

Ireland’s South East Technological University (SETU) has secured the prestigious €3.1m Innovision Cofund. The collaborative research programme focuses on addressing the challenges of global ocular disease and vision loss.

Dr Laurence Fitzhenry, the principal investigator of the Ocular Therapeutics Research Group (OTRG) and research group manager Tess Ames will lead the work. This marks the first time an Irish technological university will coordinate a Horizon Europe Marie Skłodowska-Curie cofund programme. 

Vision impairment is a major global health challenge impacting the quality of life and overall health of billions of people worldwide.

Innovision brings together a network of global partners and researchers with the aim of tackling ocular disease. Over the course of the programme, Innovision will recruit 12 experienced postdoctoral researchers to work across a global network to develop advanced projects in areas such as drug delivery, drug discovery and unique therapeutic approaches to combat vision impairment and blindness. 

“This is a global health crisis that demands urgent, innovative solutions to preserve quality of life for millions,” Fitzhenry said.

“By putting those living with ocular disease at the forefront of research, Innovision gives us the opportunity to really address this crisis.”

Commenting on the news, Prof Veronica Campbell, the SETU president said, “We are delighted to launch Innovision and work with outstanding global partners to tackle this critical challenge. This initiative not only provides a unique opportunity for researchers and industry alike to make a real difference in people’s lives, but it demonstrates that SETU and Ireland’s south-east are a driver of innovative, impactful and creative research. 

“We are especially pleased to see such strong engagement from industry partners, whose involvement will help ensure that research outcomes translate into real-world solutions for people living with vision impairment.”

Ames said that industry involvement is part of the project’s mission. “We want to continue to grow the network over the next five years, expanding the potential for impact and real-world benefits.”

SETU researchers recently secured funding from the Department of Agriculture, Food and the Marine to lead Ireland’s contribution to an international research initiative promoting sustainable and resilient food and farming via agroecological innovation.

Laura Varley
This article originally appeared on www.siliconrepublic.com and can be found here
 

You Might Also Be Interested In

  • 3 minute read
  • Published 23/09/2025

G&F Precision Molding Launches Irish Operations

G&F Precision Molding is excited to announce its expansion into Ireland, opening a new engineering and sales facility in Mullingar

Read more
  • Published 22/09/2025

Sod turned on IDA Ireland’s new Advance Building Solution in Mullingar

MULLINGAR Construction is underway on IDA Ireland’s cutting-edge Advance Building Solution (ABS)

Read more
  • 3 minute read
  • Published 19/09/2025

Alexion, AstraZeneca Rare Disease welcomes Irish partners to global operations hub in Cork, expanding opportunities for local life sciences collaboration

Alexion, AstraZeneca Rare Disease today welcomed government officials, academic leaders, and industry partners to its hub in Cork, reinforcing the company's commitment to productive partnerships and collaborative relationships within Ireland's life sciences sector

Read more